Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001394548-17-000030

Director acquired 13,814 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GALLIKER STEPHEN S Director 2017-10-10 Grant or award +13,814 $0.38 $5,249 36,039 D
Loading xslF345X03/primary_doc.xml…